SCHEMBL97231

SCHEMBL97231

O=C1NC(=O)C(=Cc2cc3ccccc3n(Cc3ccc(Cl)cc3)c2=O)S1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.59
GAA P10253 1/20 0.59
SI P14410 1/20 0.59
MGAM2 Q2M2H8 1/20 0.59
PARP1 P09874 8/20 0.52
GSK3B P49841 2/20 0.52
IGF1R P08069 1/20 0.49
PIM1 P11309 1/20 0.49
PIM2 Q9P1W9 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 1/20 0.48
PLA2G1B P04054 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
CNR1 P21554 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
TTR P02766 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97229 1.00 MGAM (0.59) MGAMGAASIMGAM2PARP1
SCHEMBL98223 0.91 MGAM (0.53) MGAMGAASIMGAM2PARP1
SCHEMBL98224 0.91 MGAM (0.53) MGAMGAASIMGAM2PARP1
SCHEMBL98313 0.82 PARP1 (0.61) MGAMGAASIMGAM2PARP1
SCHEMBL98315 0.82 PARP1 (0.61) MGAMGAASIMGAM2PARP1
SCHEMBL8685992 0.79 MGAM (0.51) MGAMGAASIMGAM2PARP1
SCHEMBL8685994 0.79 MGAM (0.51) MGAMGAASIMGAM2PARP1
SCHEMBL96881 0.78 CCR2 (0.56) MEN1KMT2ALMNAPOLBHPGD
SCHEMBL8812776 0.76 PARP1 (0.82) MGAMGAASIMGAM2PARP1
SCHEMBL8688578 0.76 PARP1 (0.82) MGAMGAASIMGAM2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 MGAM 3166/4885GAA 4784/4885SI 877/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 MGAM 3166/4885GAA 4784/4885SI 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.